DD
Invalid date
Drug Development course is an Informative and Innovative and Help full for Development of the drug after Discovering it, and Kind Request to provide the Intermediate level and Advanced level courses.
PR
Invalid date
Fantastic course, learned a lot of new things. Will go for the drug discovery course next. Consider including the presentations before the tests rather than afterwards
By SK S R
•Feb 15, 2024
knoledgable
By Sivanaga V M
•Nov 23, 2020
Good course
By Jakka B
•Aug 27, 2020
Informative
By Shivani
•Jul 23, 2020
It is good
By EARRA S
•May 30, 2020
Use full
By Ahmed S
•Jul 21, 2022
Great!
By Dr. S U
•Aug 24, 2020
useful
By Rumana F H A
•Nov 18, 2022
good
By AMAN V
•Sep 7, 2020
good
By Shweta S
•May 9, 2020
nice
By Paul G
•Jun 19, 2020
The information provided by this course was very helpful for someone who is new to the topic and I do feel much better informed as a result. The course itself however is not the most professionally presented. The recordings are of face to face lectures provided to an actual class of students. As such they are designed for online learning where there is no possibility to interact with the speakers and students don't have access to any other course materials. The speakers in the phase 3 and marketing sections didn't really follow their slide packs.
By Eliza V
•Jul 16, 2017
The overall material was good. However, the course was not structured as an online course, rather an online posting of in class lectures. This made it difficult to hear the questions of the students as the questions were not repeated by the lecturer and therefore we received an answer to a question we didn't hear. Also, because of the lecture nature, a lot of information was missing from the slides as it was spoken information.
By Mark S
•Mar 2, 2020
Several of the questions seemed irrelevant to the actual conduct of clinical research. I also wholeheartedly disagree with #7 in the phase III quiz. The real answer depends on whose perspective you're coming from. Maybe for the pharmaceutical company getting to market is most important, but to the patient I'm pretty sure efficacy is more important to him/her than how quickly other people can make money.
By Philipp L
•Mar 4, 2021
Course content was quite good up to the last third of the course. From my POV the lecturers of the third part of 'Drug Development' haven't done a good job in structuring and explaining the different aspects of Phase III and Phase IV trials. It was more jumping from one anecdotal evidence to the next while losing sight of the bigger picture.
By Maria R F
•Nov 11, 2020
The course is quite informative. I just found kind of difficult to fully understand some concepts because of the speed they are delivered. Maybe for some talks, more and more detailed slides would help for a better flow and understanding of important concepts. Overall, I enjoyed it and certainly learned a lot.
By Marie A B
•May 12, 2020
Informative and engaging in the first two weeks of lecture, however the lecturers on the third week were not that enthusiastic and I felt that I didn't gain much knowledge on them. I would suggest to refrain having two lecturers at the same time to maximize the time on the topic itself.
By Nibrass B M O
•Nov 27, 2022
The course mainly talked about the clinical trials - Thank you the details on this part - but the information on regulatory part and the regulations was not enough for me as regulatory affairs specialist, I was expecting more details on regulations and which CFR regulating each process
By Diego R
•Sep 13, 2020
This wasn't really great, it is a recording of several seminar presentations that were recorded several years ago, for this, the landscape has changed but the content hasn't, also, as this was planned for a in person presentation, the format is not optimal for a MOOC.
By Michelle R H
•May 31, 2023
The first two weeks were really interesting (5 stars), but I did not get much out of the 3rd week. The lectures were not as organized and were frequently off-topic so it made it hard to understand what the important concepts were.
By Francisco M
•Oct 12, 2020
Me ha gustado bastante, he aprendido mucho con el curso. Aún así hay un aspecto que me afecta y es que s habla muy poco de la legislación a nivel europeo y eso hace que me sea menos util para mi formación.
By Matthew L
•Jan 6, 2020
Week 3 lectures were not as in-depth as hoped and filled with too many personal anecdotes for the time allowed. Much more could have been said if these had been skipped.
By Noam S
•Aug 2, 2022
I thought that the course was informative. It would be great if lectures were up to date and may be included with more reading materials and videos to watch.
By Kayla A C
•Jun 30, 2020
Would be nice to update this course. The slides are from 2013 and I am listening in 2020. A lot has changed in the pharmaceutical market since in that time.
By Nikolai W
•Sep 25, 2019
The name of the course should be something a la 'Clincal trials and drug admistration agencies'. It is not the development of a drug.
By Mrunmai D M
•Sep 5, 2020
it was a great learning with coursera. it was indeed an informative course and glad hearing the prominent and experienced speakers